Back to Rankings

MCRB

Seres TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
MCRB vs peer average
48/100
MCRB vs. peer average (D vs. D)
Grade spread
A 1 · C 1 · D 3 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CTOR is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $73.67M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCTORCitius Oncology
MCRB
Seres Therapeutics
CTOR
Citius Oncology
Grade
D
F
Momentum
50
22
Value
42
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs CTOR

MCRB / CTOR
Grade Position
In line
MCRB vs. peer average (D vs. D)
48/100
Momentum
50
MCRB
Value
42
MCRB
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MCRB
1
CTOR
Citius Oncology Inc Common
F
20/100
+1
2
PLRX
Pliant Therapeutics Inc Common
A
100/100
-3
3
XBIT
XBiotech Inc Common
D
40/100
Even
4
RFL
Rafael Holdings Inc Class B Common
C
60/100
-1
5
FLNA
Filana Therapeutics Inc Common
F
20/100
+1
CTOR is the first peer returned for this comparison set.